We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
190 hedge funds and large institutions have $123M invested in Anavex Life Sciences in 2026 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 75 increasing their positions, 45 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
211% more call options, than puts
Call options by funds: $7.23M | Put options by funds: $2.33M
67% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 45
34% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 29
4% more funds holding
Funds holding: 183 → 190 (+7)
0.93% more ownership
Funds ownership: 42.22% → 43.15% (+0.93%)
10% less capital invested
Capital invested by funds: $136M → $123M (-$13M)
Holders
190
Holders Change
+7
Holders Change %
+3.83%
% of All Funds
2.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
75
Reduced
45
Closed
29
Calls
$7.23M
Puts
$2.33M
Net Calls
+$4.91M
Net Calls Change
+$2.36M
Top Buyers
| 1 |
Two Sigma Investments
New York
|
+$6.9M |
| 2 |
HF
HRT Financial
New York
|
+$2.85M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.63M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.41M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.93M |
